NERx Biosciences, Inc. — Form D
NERx Biosciences, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-11. The offering totals $2.5M, of which $850K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-01-11
- Form: D
- Accession: 0001764454-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $850K
- Remaining: $1.6M
- Minimum investment: $25K
- Investors: 9
- Date of first sale: 2018-12-31
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-330243
Issuer
- Name: NERx Biosciences, Inc.
- CIK: 0001764454
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 212 W 10TH ST, SUITE A480, INDIANAPOLIS, IN, 46202
- Phone: 317-612-4672
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Nicholas J Ball | Director | Indianapolis, IN |
| Nicholas J Ball | Executive Officer | Indianapolis, IN |
| John J Turchi | Director | Indianapolis, IN |
| John J Turchi | Executive Officer | Indianapolis, IN |
| Katherine J Pawelczak | Director | Indianapolis, IN |
| Katherine J Pawelczak | Executive Officer | Indianapolis, IN |
| Trent J Carrier | Director | Indianapolis, IN |
Other filings by this issuer (1)
More